These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 22644979)

  • 1. New developments in management of oral mucositis in patients with head and neck cancer or receiving targeted anticancer therapies.
    Li E; Trovato JA
    Am J Health Syst Pharm; 2012 Jun; 69(12):1031-7. PubMed ID: 22644979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of palifermin: amelioration of oral mucositis and other potential indications.
    Vadhan-Raj S; Goldberg JD; Perales MA; Berger DP; van den Brink MR
    J Cell Mol Med; 2013 Nov; 17(11):1371-84. PubMed ID: 24251854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
    Henke M; Alfonsi M; Foa P; Giralt J; Bardet E; Cerezo L; Salzwimmer M; Lizambri R; Emmerson L; Chen MG; Berger D
    J Clin Oncol; 2011 Jul; 29(20):2815-20. PubMed ID: 21670447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of laser for the prevention and treatment of oral mucositis induced by radiotherapy and chemotherapy for head and neck cancer].
    Muñoz-Corcuera M; González-Nieto A; López-Pintor Muñoz RM
    Med Clin (Barc); 2014 Aug; 143(4):170-5. PubMed ID: 24216016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
    Le QT; Kim HE; Schneider CJ; Muraközy G; Skladowski K; Reinisch S; Chen Y; Hickey M; Mo M; Chen MG; Berger D; Lizambri R; Henke M
    J Clin Oncol; 2011 Jul; 29(20):2808-14. PubMed ID: 21670453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer treatment-induced oral mucositis: a critical review.
    Rodríguez-Caballero A; Torres-Lagares D; Robles-García M; Pachón-Ibáñez J; González-Padilla D; Gutiérrez-Pérez JL
    Int J Oral Maxillofac Surg; 2012 Feb; 41(2):225-38. PubMed ID: 22071451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis.
    Scully C; Epstein J; Sonis S
    Head Neck; 2004 Jan; 26(1):77-84. PubMed ID: 14724910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis.
    Daugėlaitė G; Užkuraitytė K; Jagelavičienė E; Filipauskas A
    Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30678228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photobiomodulation in oral mucositis in patients with head and neck cancer: a systematic review and meta-analysis followed by a cost-effectiveness analysis.
    Campos TM; do Prado Tavares Silva CA; Sobral APT; Sobral SS; Rodrigues MFSD; Bussadori SK; Fernandes KPS; Mesquita-Ferrari RA; Horliana ACRT; Motta LJ
    Support Care Cancer; 2020 Dec; 28(12):5649-5659. PubMed ID: 32666214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation.
    Weigelt C; Haas R; Kobbe G
    Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):505-15. PubMed ID: 21417820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
    Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
    Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant.
    Beaven AW; Shea TC
    Drugs Today (Barc); 2007 Jul; 43(7):461-73. PubMed ID: 17728847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A research review of the current treatments for radiation-induced oral mucositis in patients with head and neck cancer.
    Shih A; Miaskowski C; Dodd MJ; Stotts NA; MacPhail L
    Oncol Nurs Forum; 2002 Aug; 29(7):1063-80. PubMed ID: 12183755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy and/or molecular targeted therapy].
    Zhang XX; Ma L; Wang JL; Wu WM; Feng LC; Huang DL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):505-8. PubMed ID: 21924104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.
    Trotti A; Bellm LA; Epstein JB; Frame D; Fuchs HJ; Gwede CK; Komaroff E; Nalysnyk L; Zilberberg MD
    Radiother Oncol; 2003 Mar; 66(3):253-62. PubMed ID: 12742264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies.
    Elting LS; Cooksley CD; Chambers MS; Garden AS
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1110-20. PubMed ID: 17398022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.
    De Sanctis V; Bossi P; Sanguineti G; Trippa F; Ferrari D; Bacigalupo A; Ripamonti CI; Buglione M; Pergolizzi S; Langendjik JA; Murphy B; Raber-Durlacher J; Russi EG; Lalla RV
    Crit Rev Oncol Hematol; 2016 Apr; 100():147-66. PubMed ID: 26947812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer.
    Ueno T; Zenda S; Konishi T; Yurikusa T; Shibasaki Y; Nagamoto H; Fujii M
    Int J Clin Oncol; 2019 Mar; 24(3):241-247. PubMed ID: 30426268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.